DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL… Application US-20210214425-A1 United States of America 15 Jul 2021
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement Grant US-10703809-B1 United States of America 07 Jul 2020
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement Grant US-10590189-B2 United States of America 17 Mar 2020